Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Optimal production of L-threo-2,3-dihydroxyphenylserine (L-threo-DOPS) on a large scale by diastereoselectivity-enhanced variant of L-threonine aldolase expressed in Escherichia coli.

Gwon HJ, Yoshioka H, Song NE, Kim JH, Song YR, Jeong DY, Baik SH.

Prep Biochem Biotechnol. 2012;42(2):143-54. doi: 10.1080/10826068.2011.583975.

PMID:
22394063
[PubMed - indexed for MEDLINE]
2.

Enhanced synthesis of L-threo-3,4-dihydroxyphenylserine by high-density whole-cell biocatalyst of recombinant L-threonine aldolase from Streptomyces avelmitilis.

Baik SH, Yoshioka H.

Biotechnol Lett. 2009 Mar;31(3):443-8. doi: 10.1007/s10529-008-9885-0. Epub 2008 Nov 28.

PMID:
19039530
[PubMed - indexed for MEDLINE]
3.

Diastereoselective synthesis of L: -threo-3,4-dihydroxyphenylserine by low-specific L: -threonine aldolase mutants.

Gwon HJ, Baik SH.

Biotechnol Lett. 2010 Jan;32(1):143-9. doi: 10.1007/s10529-009-0125-z. Epub 2009 Sep 17.

PMID:
19760118
[PubMed - indexed for MEDLINE]
4.

Synthesis of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) with thermostabilized low-specific L-threonine aldolase from Streptomyces coelicolor A3(2).

Balk SH, Yoshioka H, Yukawa H, Harayama S.

J Microbiol Biotechnol. 2007 May;17(5):721-7.

PMID:
18051291
[PubMed - indexed for MEDLINE]
5.

[Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].

Fujiwara H, Inagaki C, Ikeda Y, Tanaka C.

Nihon Yakurigaku Zasshi. 1976 Oct;72(7):891-8. Japanese.

PMID:
14060
[PubMed - indexed for MEDLINE]
6.

L-threo-3,4-dihydroxyphenylserine (DOPS) aldolase: a new enzyme cleaving DOPS into protocatechualdehyde and glycine.

Naoi M, Takahashi T, Kuno N, Nagatsu T.

Biochem Biophys Res Commun. 1987 Mar 13;143(2):482-8.

PMID:
3105531
[PubMed - indexed for MEDLINE]
7.

A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.

Maruyama W, Nakahara D, Naoi M.

J Neural Transm Park Dis Dement Sect. 1994;7(1):21-33.

PMID:
8579767
[PubMed - indexed for MEDLINE]
8.

Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.

Ohmura I, Inagaki C, Araki H, Tanaka C.

Jpn J Pharmacol. 1978 Oct;28(5):747-53.

PMID:
31501
[PubMed - indexed for MEDLINE]
Free Article
9.

A new route to L-threo-3-[4-(methylthio)phenylserine], a key intermediate for the synthesis of antibiotics: recombinant low-specificity D-threonine aldolase-catalyzed stereospecific resolution.

Liu JQ, Odani M, Dairi T, Itoh N, Shimizu S, Yamada H.

Appl Microbiol Biotechnol. 1999 May;51(5):586-91.

PMID:
10390816
[PubMed - indexed for MEDLINE]
10.
11.

L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.

Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD.

Clin Auton Res. 2001 Aug;11(4):235-42.

PMID:
11710796
[PubMed - indexed for MEDLINE]
13.

Serine hydroxymethyl transferase from Streptococcus thermophilus and L-threonine aldolase from Escherichia coli as stereocomplementary biocatalysts for the synthesis of beta-hydroxy-alpha,omega-diamino acid derivatives.

Gutierrez ML, Garrabou X, Agosta E, Servi S, Parella T, Joglar J, Clap├ęs P.

Chemistry. 2008;14(15):4647-56. doi: 10.1002/chem.200800031.

PMID:
18384024
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.

Suzuki T, Higa S, Sakoda S, Ueji M, Hayashi A, Takaba Y, Nakajima A.

Eur J Clin Pharmacol. 1982;23(5):463-8.

PMID:
6818040
[PubMed - indexed for MEDLINE]
15.

Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.

Yamamoto M, Ujike H, Ogawa N.

Clin Neuropharmacol. 1985;8(4):334-42.

PMID:
2416437
[PubMed - indexed for MEDLINE]
16.

Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.

Araki H, Tanaka C, Fujiwara H, Nakamura M, Ohmura I.

J Pharm Pharmacol. 1981 Dec;33(12):772-7.

PMID:
6121848
[PubMed - indexed for MEDLINE]
17.

Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.

Morimoto S, Matsumura Y, Ohyama T, Shinyama H, Ichihara T, Takahashi Y, Hisaki K.

Jpn J Pharmacol. 1990 Mar;52(3):431-9.

PMID:
2110272
[PubMed - indexed for MEDLINE]
Free Article
18.

[Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].

Yamazaki M, Ikeda Y, Ishikawa M, Inagaki C, Tanaka C.

Nihon Yakurigaku Zasshi. 1976 Apr;72(3):363-9. Japanese.

PMID:
986992
[PubMed - indexed for MEDLINE]
19.

Gene cloning, biochemical characterization and physiological role of a thermostable low-specificity L-threonine aldolase from Escherichia coli.

Liu JQ, Dairi T, Itoh N, Kataoka M, Shimizu S, Yamada H.

Eur J Biochem. 1998 Jul 1;255(1):220-6.

PMID:
9692922
[PubMed - indexed for MEDLINE]
Free Article
20.

Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.

Soares-da-Silva P.

Gen Pharmacol. 1993 Jan;24(1):75-81.

PMID:
8482506
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk